🕵️ Acadia Pharmaceuticals Inc ($ACAD)
SEC insider & ownership activity, last 12 months · CIK 1070494 · every row links its SEC filing
Over the last 12 months insiders sold $3.1M with no open-market buying against it. Mark C. Schneyer sold $1.2M (Aug–May). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 7 sellers, $3.1M (22 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Mark C. Schneyer | 0 | – | 8 | $1.2M | May 4, 2026 |
| James M. Daly | 0 | – | 1 | $671K | Nov 10, 2025 |
| Kihara James | 0 | – | 8 | $603K | Jun 26, 2026 |
| Owen Adams Catherine | 0 | – | 1 | $250K | Mar 25, 2026 |
| Jennifer J. Rhodes | 0 | – | 2 | $245K | Mar 25, 2026 |
| Thompson Elizabeth H.z. | 0 | – | 1 | $74K | Mar 25, 2026 |
| Elizabeth A. Garofalo | 0 | – | 1 | $42K | Sep 2, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Julian C. Baker | 25.4% | 13D | Feb 24, 2026 | filing ↗ | |
| Felix J. Baker | 25.4% | 13D | Feb 24, 2026 | filing ↗ | |
| Baker BROS. Advisors LP | 25.3% | 13D | Feb 24, 2026 | filing ↗ | |
| Baker BROS. Advisors (GP) LLC | 25.3% | 13D | Feb 24, 2026 | filing ↗ | |
| Blackrock, Inc. | 11.9% | 13G | Feb 7, 2025 | filing ↗ | |
| Roderick WONG, M.D. | 5.2% | 13G | Feb 14, 2025 | filing ↗ | |
| Vanguard Portfolio Management | 5.2% | 13G | Apr 28, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Kihara James | $297K | Jun 26, 2026 | filing ↗ |
| James K Kihara | $114K | May 26, 2026 | filing ↗ |
| James M Daly | $671K | Nov 10, 2025 | filing ↗ |
| Mark C. Schneyer | $557K | Aug 18, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | May 29, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 29, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 29, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 3, 2026 | filing ↗ |
| Earnings (2.02) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Earnings (2.02) | Jan 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 13, 2026 | filing ↗ |
| Earnings (2.02) | Nov 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 5, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 28, 2025 | filing ↗ |
| Earnings (2.02) | Aug 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2025 | filing ↗ |